SVP, Global Biotherapeutics Quality
Just-Evotec, Biologics
Sundar Ramanan, PhD, MBA, is Senior Vice President of Global Biotherapeutic Quality at
Just-Evotec Biologics. With more than 20 years of experience in the biotechnology industry,
he is a seasoned executive with broad expertise across biopharmaceutical drug development,
operations, clinical and commercial strategy, policy, and regulatory affairs. Before joining JustEvotec, he was the Vice President and Global Head of Regulatory Affairs at Biocon Biologics, where he engaged with key stakeholders to advance industry-shaping policy, resulting in the Phase 3 waiver for insulin biosimilars. He also led teams in obtaining the first US FDA approval for an interchangeable biosimilar. Before Biocon, Ramanan worked at Amgen, where he was responsible for international regulatory strategy and policy for biologics and biosimilars. He has led teams in the successful development and approvals of several biopharmaceutical drug candidates, from the early stages through commercialization and lifecycle management across multiple therapeutic areas, including oncology, hematology, inflammation, metabolic disorders, general medicine, and rare diseases. Ramanan received a PhD in bioengineering from Oregon State University and an MBA from the University of Michigan.
Disclosure information not submitted.
Sunday, September 11, 2022
8:30 AM – 4:00 PM MST